MBX Capital
Venture capitalActively deployingClaymont · Pre-Seed–Series A · 4 people tracked
Also known as MBX Capital NYS SSBCI · MBX CAPITAL, LLC
Investment thesis
MBX Capital invests at the early stage in what it calls 'deep health' — a broad range of health-focused companies spanning drug discovery, diagnostics, therapeutics, medical AI, care delivery, mental and maternal health, and adjacent green chemistry and life-sciences infrastructure. The firm frequently partners alongside other investors and aims to advance good health for everyone, backing visionary founders tackling significant biological, clinical, and healthcare-access challenges.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directoriesWhat they invest in
from 16 of 41 portfolio companiesHealthtech ×10Biotech ×8AI & Machine Learning ×7Digital Health ×6Medical Devices ×6Deep Tech ×4Mental Health ×2AgTech ×1
HQs:United States×10Mexico×1
Investments · 41 tracked
founders shown can be your intro pathBiotechCharlottesville, US
Kevin S Eisenfrats(Executive Officer, Director, Promoter)Iris Van Alderwerelt van Rosenburgh(Director)Martin J Emerson(Director)Gurdane Bhutani(Director)Tom Thorpe(Director)Michael King(Director)
Board seatGurdane Bhutani· per SEC Form D · $115.9M raise · filed Jun 2026
Junction Health partners with Federally Qualified Health Centers (FQHCs) to set up and manage IV infusion therapy sites, expanding access to infusion services for chronically ill, uninsured, Medicaid, and underserved patients across the US.
Digital HealthHealthtechImpact & Social GoodMedical DevicesDenver, US
Vincent Joseph Polito(Executive Officer, Director)Matthew Adam Vestal(Executive Officer, Director)Jason Hill(Director)Ben Richard Wiederholt(Executive Officer, Director)Gurdane Bhutani(Director)Ben Wiederholt(Co-founder & CEO)
Board seatGurdane Bhutani· per SEC Form D
BiotechGreenwood Village, US
Rajeev Kumar(Executive Officer, Director)Gurdane Bhutani(Director)
Board seatGurdane Bhutani· per SEC Form D · $6.5M raise · filed Jul 2026
Arine provides an AI-driven medication management platform for health plans to improve medication adherence and outcomes.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Yoona Kim(Executive Officer, Director)Ben Thomander(Executive Officer)Andrew Brooks(Director)Penjit Moorehead(Executive Officer, Director)Perry Wallack(Director)Eric Carlson(Chief Financial Officer)
Atlas Health uses AI-driven patient assistance to help health systems connect patients to financial resources and reduce barriers to care.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtech
Biomaterial vaccine platform for infectious and chronic diseases.
Protein coupling technology to create better vaccines and medicines for auto-immune diseases.
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Improving access to quality dental healthcare throughout India.
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Dr. Sam Gambhir(Founder)Cyriac Roeding(Co-founder)Dr. David Suhy(Co-founder & Chief Scientific Officer)Justin Kao(Director)Jorge Conde(Director)
Engineered receptors to control cell signaling.
Making world-class radiology technology available in LATAM.
Eva Center offers Eden, a cloud-native RIS/PACS platform for radiology departments and diagnostic imaging institutions, featuring fast DICOM loading, medical-grade image viewers with multiplanar and 3D reconstruction, voice dictation, scheduling, referring-physician portals, and digital delivery of results.
HealthtechMedical DevicesSaaS
Cloud infrastructure for computational chemistry.
Industry-best AI for medical coding.
Making peer support accessible for people navigating life's biggest challenges.
Novel ketamine formulations for treatment resistant depression.
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.
BiotechDigital HealthMental Health
Dr. John Krystal(Co-founder & CEO)Dina Burkitbayeva(Co-founder)
Psychedelic therapies for addiction.
A new standard of care in IVF preimplantation genetic testing.
Preimplantation genetic testing (PGT) and diagnostics
Keebler is an AI-powered risk adjustment platform designed to identify and document revenue opportunities for health plans and providers through automated HCC coding support.
AI & Machine LearningHealthtech
Closing the maternal health gap for minority mothers.
Reducing wait times for surgical procedures for Medicaid members.
OFFOR Health provides mobile healthcare services to underserved populations in the United States, operating SmileMD for in-office anesthesia and sedation during pediatric dental procedures and IH Care+ for integrated health access.
Digital HealthHealthtechMedical DevicesWorthington, US
Gary Schafer(Chief Executive Officer)Alex Ramos(Chief Operations Officer)Brian Schloss(Chief Medical Officer)
Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
AI & Machine LearningBiotechHealthtechMedical DevicesRoboticsSacramento, US
Tidal Vision develops scalable chitosan solutions for applications in water treatment, agriculture, and material science.
AgTechCleantechNew MaterialsBellingham, US
Edward Schutter(Director)Roeland van der Molen(Director)Arkadi Nachimowski(Director)Filipp Chebotarev(Director)Zachary Wilkinson(Director)Amrit Jalan(Director)
Synthetic peptide vaccines for chronic diseases.
Bringing lab testing to point-of-care.
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development.
AI & Machine LearningBiotechDeep TechBrisbane, US
Julie O'Shaughnessy(Director)Andrei Georgescu(Executive Officer, Director)Quinten Stevens(Director)Alex Andrianopolous(Director)Dongeun Huh(Executive Officer, Director)ALEX ANDRIANOPOULOS(Director)
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep Tech
Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does MBX Capital invest at?
- MBX Capital invests at the Pre-Seed, Seed, Series A stages.
- What is MBX Capital's typical check size?
- MBX Capital typically writes checks of $250K – $2.5M.
- What sectors does MBX Capital focus on?
- MBX Capital focuses on AI & Machine Learning, Biotech, Digital Health, FemTech, Healthtech, Medical Devices, Mental Health.
- Where is MBX Capital located?
- MBX Capital is headquartered in Claymont, US.
- Does MBX Capital lead rounds?
- MBX Capital typically participates in rounds rather than leading them.
Co-investors · 9
General Catalyst is a venture capital and investment firm that backs founders across industries, with a strong focus on AI-driven transformation, fintech, healthcare, and other sectors.
Uber is a technology company operating multisided platforms that connect consumers with ride services, transit, delivery of food and groceries, and freight shipping across more than 70 countries and 15,000+ cities.
Plug and Play is an innovation platform that connects corporations, governments, startups, investors, and universities to drive innovation.
Cota Capital is an investment firm focused on founders building net-new enterprise technology, combining capital with operational expertise, industry insight, competitive intelligence, and a broad network.
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
Pear VC is an early-stage venture firm specializing in pre-seed and seed investments, run by former founders and operators who provide recruiting, sales coaching, and fundraising support to portfolio companies.
23andMe Research Institute is a genetic research organization that unites a community of 11 million members to advance health discoveries and deepen understanding of human DNA through collaborative research. The institute operates a cycle where members contribute genetic data that fuels research, which produces insights and breakthroughs that flow back to members and society.
Biospring Partners invests in technology-enabled, EBITDA-positive pharma services businesses focused on advancing manufacturing and clinical trial services for the life sciences industry.
Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.
Firms observed investing alongside MBX Capital, from public investor directories. Shared companies are the overlap with MBX Capital's recorded portfolio.
Similar investors
MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
W Health Ventures is an investment firm and healthcare-focused venture studio that builds healthcare companies from scratch across India, the US and beyond.












